 |
answer text |
<p>The Department regularly reviews performance against the objectives, deliverables
and requirements in the Government’s mandate to NHS England. The result of this assessment
is set out in the Department’s annual assessment.</p><p> </p><p>The upper quartile
strategic goal in the Life Science Industrial Strategy is not government policy and
will therefore not be part of the Annual Assessment process. However, partners across
the system are committed to maximising the appropriate use of innovative medicines
to deliver better patient outcomes and support the long-term sustainability of the
National Health Service. The Government continues to support and improve the Innovation
Scorecard which tracks the uptake of innovative products approved by the National
Institute for Health and Care Excellence. It is designed to help users (clinicians,
patients, commissioning groups, Government and other stakeholders) to understand and
monitor the uptake of innovations in the NHS, and to use this information to continue
to improve performance. We are continuing to increase the number of products covered
by the scorecard, as well as to widen the range of medical technologies covered, including
innovative diagnostic and digital products.</p>
|
|
